A US-based national surveillance study for the susceptibility and epidemiology of Clostridioides difficile isolates with special reference to ridinilazole: 2020-2021
美国针对艰难梭菌分离株敏感性和流行病学开展的国家监测研究（特别关注瑞丁唑）：2020-2021 年
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.1
doi:10.1128/aac.00349-23
D R Snydman, L A McDermott, C M Thorpe, E J C Goldstein, A N Schuetz, S Johnson, D N Gerding, L Gluck, D Bourdas, K C Carroll, C K Lancaster, K W Garey, Q Wang, S T Walk, E Duperchy1
